PUBLISHER: TechNavio | PRODUCT CODE: 1681245
PUBLISHER: TechNavio | PRODUCT CODE: 1681245
The animal biotechnology market is forecasted to grow by USD 4465.1 million during 2024-2029, accelerating at a CAGR of 3.3% during the forecast period. The report on the animal biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing growth strategies of market players, growing focus on animal cloning, and use of transgenic animals to produce recombinant proteins.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 3.1% |
CAGR | 3.3% |
Incremental Value | $4465.1 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's animal biotechnology market is segmented as below:
By Product
By Animal Type
By Technology
By Product Type
By Geographical Landscape
This study identifies the increasing prevalence of animal diseases as one of the prime reasons driving the animal biotechnology market growth during the next few years. Also, emergence of alternatives to animal testing and advancements in research and development for animal biotechnology will lead to sizable demand in the market.
The report on the animal biotechnology market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal biotechnology market vendors that include Anicell BioTech, Bayer AG, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., EW Group GmBH, Genus PLC, Heska Corp., Hester Biosciences Ltd., IDEXX Laboratories Inc., INDICAL Bioscience GmbH, Ivaoes LLC, Merck and Co. Inc., Neogen Corp., Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., Virbac Group, Z Link Biotech Co. Ltd., Zeus Biotech Pvt. Ltd., and Zoetis Inc.. Also, the animal biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.